CVS Health (NYSE: CVS) reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $47.3 billion versus the consensus estimate of $47.2 billion.

GUIDANCE:

CVS Health sees FY2018 EPS of $6.98-$7.08, versus the consensus of $7.05.

For earnings history and earnings-related data on CVS Health (CVS) click here.